The Oxytocin Market is anticipated to grow from USD 122.490 million in 2025 to USD 157.078 million by 2030, registering a 5.10% CAGR.
Oxytocin is a hormone that is given to women during pregnancy generally when there are childbirth complications in order to induce labor or support and make the uterine contractions strong. The prevalence of childbirth complications has been increasing over the years and is expected to propel the growth of the oxytocin market during the forecast period. Furthermore, the increasing access to hospitals and medical facilities is leading to a higher number of women giving birth in hospitals now, which is further expected to boost the market growth of oxytocin during the assessment period. However, the partial ban on oxytocin by various countries is projected to hamper the market growth in the coming years.
The cases of childbirth complications have been increasing over the years and are projected to continue growing in the coming years as well, which is anticipated to bolster the growth of the oxytocin market during the forecast period, as the medicine is widely used in childbirth complications. The Blue Cross Blue Shield Association states that women with pregnancy complications have twice the chance of having childbirth complications as well. As per the report titled "Trends in Pregnancy and Childbirth Complications in the U.S." published in June 2020, pregnancy complications have increased by 16.4% and childbirth complications have increased from 14.2% during the period from 2014 to 2018. The childbirth complication with the highest growth between 2014 and 2018 was eclampsia, as per the Blue Cross Blue Shield Association. The prevalence rate of eclampsia in the United States has increased from 1.1 per 1,000 cases to 1.7 per 1,000 cases, witnessing a growth of 57.9% between 2014 and 2018. Other complications such as cardiomyopathy, embolism, sepsis, and respiratory distress have also been witnessing growth in their prevalence. The growing cases of childbirth complications are leading to an increased need for oxytocin to induce labor or strengthen uterine contractions, or control bleeding after childbirth. The growing trend of childbirth defects is expected to continue supplementing the market growth of oxytocin during the forecast period.
Geographically, the North American region is anticipated to hold a significant market share owing to the presence of an advanced healthcare system and high awareness in the region regarding pregnancy and childbirth complications. The Asia Pacific region is anticipated to witness substantial growth due to increasing access to medical facilities for pregnant women.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Oxytocin Market Size in 2025 | USD 122.490 million |
| Oxytocin Market Size in 2030 | USD 157.078 million |
| Growth Rate | CAGR of 5.10% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Million |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in Oxytocin Market |
|
| Customization Scope | Free report customization with purchase |
Segmentation